We can expect the pharmaceuticals market to be significantly reshaped, with a greater emphasis on value and a need for a more complete package of products and services. At Cirio, we advise organisations in the drug development phase and later throughout the product life cycle, to meet current challenges and seize opportunities. Cirio’s experienced pharmaceuticals experts understand the unique risks and challenges faced by industry participants, such as drug safety and efficacy, clinical trials and commercialisation, IP protection, pricing and reimbursement, as well as regulatory approval and compliance. Cirio is also uniquely qualified to assist in transactions involving pharmaceutical development/products, such as seed/venture capital financing, M&A, partnering/licensing arrangements, IPOs, and public takeovers.